International Clinical Trial: Application of ICG@HSA Complex Counterstain Fluorescence Imaging in Laparoscopic Anatomical Hepatectomy: A Multicenter, Prospective, Double-Blind, Randomized Controlled Study

Geneva, March 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600119495) titled 'Application of ICG@HSA Complex Counterstain Fluorescence Imaging in Laparoscopic Anatomical Hepatectomy: A Multicenter, Prospective, Double-Blind, Randomized Controlled Study' on Feb. 27.

Study Type: Interventional study

Study Design: Parallel

Primary Sponsor: West China Hospital of Sichuan University

Condition: Hepatocellular carcinoma

Intervention: New drug delivery group:After ligating the target liver segment's portal vein, use a new ICG formulation (add 0.5 mg of ICG powder and 500 mg of human albumin to 20 ml of saline, shake well and let stand for more than 5 minutes ICG 0.025 mg/ml, human albumin ...